Perspective of αvβ6-Integrin Imaging for Clinical Management of Pancreatic Carcinoma and Its Precursor Lesions

Familial pancreatic cancer: Concept, management and issues

(2017) Hiroyuki Matsubayashi et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypes

(2017) Anna Melissa Schlitter et al.   Scientific Reports

In Vivo PET Imaging of the Cancer Integrin αvβ6 Using 68 Ga-Labeled Cyclic RGD Nonapeptides

(2016) Johannes Notni et al.   JOURNAL OF NUCLEAR MEDICINE

CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma

(2016) Elisa M Noll et al.   NATURE MEDICINE

Stable Peptides Instead of Stapled Peptides: Highly Potent αvβ6-Selective Integrin Ligands

(2015) Oleg V. Maltsev et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Phosphinic Acid Functionalized Polyazacycloalkane Chelators for Radiodiagnostics and Radiotherapeutics: Unique Characteristics and Applications

(2014) Johannes Notni et al.   ChemMedChem

FDG-PET is not useful in early pancreatic cancer diagnosis

(2013) Oliver Strobel et al.   Nature Reviews Gastroenterology & Hepatology

Japan Pancreatic Cancer Registry; 30th Year Anniversary

(2012) Shinichi Egawa et al.   PANCREAS

Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues

(2011) Michaela Aichler et al.   JOURNAL OF PATHOLOGY

Targeted In vivo Imaging of Integrin  v 6 with an Improved Radiotracer and Its Relevance in a Pancreatic Tumor Model

(2009) S. H. Hausner et al.   CANCER RESEARCH

Integrin ανβ6 Acts as a Prognostic Indicator in Gastric Carcinoma

(2007) Z.-Y. Zhang et al.   CLINICAL ONCOLOGY